Varghese Z - Search Results

1

EPA and DHA reduce LPS-induced inflammation responses in HK-2 cells: evidence for a PPAR-gamma-dependent mechanism.

Li H, Ruan XZ, Powis SH, Fernando R, Mon WY, Wheeler DC, Moorhead JF, Varghese Z. Li H, et al. Among authors: varghese z. Kidney Int. 2005 Mar;67(3):867-74. doi: 10.1111/j.1523-1755.2005.00151.x. Kidney Int. 2005. PMID: 15698426 Free article.

2

Effects of dietary fatty acids in an animal model of focal glomerulosclerosis.

Wheeler DC, Nair DR, Persaud JW, Jeremy JY, Chappell ME, Varghese Z, Moorhead JF. Wheeler DC, et al. Among authors: varghese z. Kidney Int. 1991 May;39(5):930-7. doi: 10.1038/ki.1991.116. Kidney Int. 1991. PMID: 2067209 Free article.

3

Simvastatin therapy for hypercholesterolemic patients with nephrotic syndrome or significant proteinuria.

Thomas ME, Harris KP, Ramaswamy C, Hattersley JM, Wheeler DC, Varghese Z, Williams JD, Walls J, Moorhead JF. Thomas ME, et al. Among authors: varghese z. Kidney Int. 1993 Nov;44(5):1124-9. doi: 10.1038/ki.1993.358. Kidney Int. 1993. PMID: 8264145 Free article. Clinical Trial.

4

Lipopheresis in the nephrotic syndrome.

Brunton C, Varghese Z, Moorhead JF. Brunton C, et al. Among authors: varghese z. Kidney Int Suppl. 1999 Jul;71:S6-9. doi: 10.1046/j.1523-1755.1999.07102.x. Kidney Int Suppl. 1999. PMID: 10412726 Free article. Clinical Trial.

5

Human mesangial cells express inducible macrophage scavenger receptor.

Ruan XZ, Varghese Z, Powis SH, Moorhead JF. Ruan XZ, et al. Among authors: varghese z. Kidney Int. 1999 Aug;56(2):440-51. doi: 10.1046/j.1523-1755.1999.00587.x. Kidney Int. 1999. PMID: 10432382 Free article.

6

Oral L-arginine does not improve endothelial dysfunction in children with chronic renal failure.

Bennett-Richards KJ, Kattenhorn M, Donald AE, Oakley GR, Varghese Z, Bruckdorfer KR, Deanfield JE, Rees L. Bennett-Richards KJ, et al. Among authors: varghese z. Kidney Int. 2002 Oct;62(4):1372-8. doi: 10.1111/j.1523-1755.2002.kid555.x. Kidney Int. 2002. PMID: 12234308 Free article. Clinical Trial.

7

Inflammation modifies lipid-mediated renal injury.

Ruan XZ, Varghese Z, Moorhead JF. Ruan XZ, et al. Among authors: varghese z. Nephrol Dial Transplant. 2003 Jan;18(1):27-32. doi: 10.1093/ndt/18.1.27. Nephrol Dial Transplant. 2003. PMID: 12480956 Review. No abstract available.

8

PPAR agonists protect mesangial cells from interleukin 1beta-induced intracellular lipid accumulation by activating the ABCA1 cholesterol efflux pathway.

Ruan XZ, Moorhead JF, Fernando R, Wheeler DC, Powis SH, Varghese Z. Ruan XZ, et al. Among authors: varghese z. J Am Soc Nephrol. 2003 Mar;14(3):593-600. doi: 10.1097/01.asn.0000050414.52908.da. J Am Soc Nephrol. 2003. PMID: 12595494 Free article.

9

Effects of sirolimus on mesangial cell cholesterol homeostasis: a novel mechanism for its action against lipid-mediated injury in renal allografts.

Varghese Z, Fernando R, Moorhead JF, Powis SH, Ruan XZ. Varghese Z, et al. Am J Physiol Renal Physiol. 2005 Jul;289(1):F43-8. doi: 10.1152/ajprenal.00181.2004. Epub 2005 Mar 15. Am J Physiol Renal Physiol. 2005. PMID: 15769938 Free article.

10

Nuclear receptors and their coregulators in kidney.

Ruan XZ, Varghese Z, Powis SH, Moorhead JF. Ruan XZ, et al. Among authors: varghese z. Kidney Int. 2005 Dec;68(6):2444-61. doi: 10.1111/j.1523-1755.2005.00721.x. Kidney Int. 2005. PMID: 16316322 Free article. Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

Search Page

Search Results